Anti-CD19 CAR-T as a feasible and safe treatment against central nervous system leukemia after intrathecal chemotherapy in adults with relapsed or refractory B-ALL.

ABSTRACT:

SUBMITTER: He X 

PROVIDER: S-EPMC6756216 | biostudies-literature | 2019 Aug

REPOSITORIES: biostudies-literature